Zacks Investment Research on MSN
LivaNova reports improved OSA outcomes with PolySync programming
LivaNova LIVN recently announced new data from the PolySync substudy showing that its PolySync programming algorithm increased the cumulative apnea-hypopnea index (AHI) response rate from 65% to 84.5% ...
LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced new data showing that use of its PolySync™ programming algorithm increased the ...
New data from LivaNova has demonstrated the clinical benefit of its programming algorithm in patients with obstructive sleep apnoea (OSA). Trial data demonstrated that the company's PolySync ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results